{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:28:19Z","timestamp":1786652899260,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["NAF\\\\R10\\\\100041"],"award-info":[{"award-number":["NAF\\\\R10\\\\100041"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xphs.2025.103992","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:58:00Z","timestamp":1758056280000},"page":"103992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced terbinafine topical delivery to the nail by new formulation\u2013microporation approaches"],"prefix":"10.1016","volume":"115","author":[{"given":"Camila de Almeida Perez","family":"Pimenta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Kishishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2211-2882","authenticated-orcid":false,"given":"Yohana Souza","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Am\u00e9lia Moreira","family":"Lira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2233-7654","authenticated-orcid":false,"given":"M.Bego\u00f1a","family":"Delgado-Charro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila Bastos","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.103992_bib0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2008.01.027","article-title":"Chemical method to enhance transungual transport and iontophoresis efficiency","volume":"357","author":"Hao","year":"2008","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2025.103992_bib0002","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s11095-007-9368-3","article-title":"Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers","volume":"24","author":"Khengar","year":"2007","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2025.103992_bib0003","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2133.2011.10303.x","article-title":"Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation","volume":"165","author":"Monti","year":"2011","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.xphs.2025.103992_bib0004","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1517\/17425240802497218","article-title":"Enhancing the nail permeability of topically applied drugs","volume":"5","author":"Murdan","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"10.1016\/j.xphs.2025.103992_bib0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s13346-016-0287-x","article-title":"Formulation development and optimization of transungual drug delivery system of terbinafine hydrochloride for the treatment of onychomycosis","volume":"6","author":"Patel","year":"2016","journal-title":"Drug Deliv Transl Res"},{"issue":"5","key":"10.1016\/j.xphs.2025.103992_bib0006","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2710.2009.01107.x","article-title":"Toenail onychomycosis: an important global disease burden","volume":"35","author":"Thomas","year":"2010","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"10.1016\/j.xphs.2025.103992_bib0007","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/pharmaceutics10040276","article-title":"Polyurethanes as new excipients in nail therapeutics","volume":"10","author":"Valdes","year":"2018","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.xphs.2025.103992_bib0008","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1203475417716362","article-title":"Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment","volume":"21","author":"Gupta","year":"2017","journal-title":"J Cutan Med Surg"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.103992_bib0009","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2012.06.020","article-title":"Hydration of nail plate: a novel screening model for transungual drug permeation enhancers","volume":"436","author":"Chouhan","year":"2012","journal-title":"Int J Pharm"},{"issue":"Suppl 65","key":"10.1016\/j.xphs.2025.103992_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.149.s65.4.x","article-title":"Epidemiology, clinical presentation and diagnosis of onychomycosis","volume":"149","author":"Faergemann","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xphs.2025.103992_bib0011","series-title":"Topical Nail Products and Ungual Drug Delivery","first-page":"1","article-title":"The nail: anatomy, physiology, diseases and treatment","author":"Murdan","year":"2012"},{"issue":"3","key":"10.1016\/j.xphs.2025.103992_bib0012","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0733-8635(18)30884-2","article-title":"Onychomycosis","volume":"3","author":"Zaias","year":"1985","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.xphs.2025.103992_bib0013","first-page":"445","article-title":"Tavaborole for the treatment of onychomycosis","volume":"15","author":"Elewski","year":"2014","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.xphs.2025.103992_bib0014","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11046-009-9265-x","article-title":"Iontophoretic terbinafine HCl 1% delivery across porcine and human nails","volume":"169","author":"Amichai","year":"2010","journal-title":"Mycopathologia"},{"issue":"10","key":"10.1016\/j.xphs.2025.103992_bib0015","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3109\/03639045.2011.568946","article-title":"Transungual delivery of terbinafine by iontophoresis in onychomycotic nails","volume":"37","author":"Nair","year":"2011","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2025.103992_bib0016","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jconrel.2017.10.014","article-title":"Precise laser poration to control drug delivery into and through human nail","volume":"268","author":"Vanstone","year":"2017","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.xphs.2025.103992_bib0017","first-page":"828","article-title":"How low should you go: novel device for nail trephination","volume":"32","author":"Ciocon","year":"2006","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.xphs.2025.103992_bib0018","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/pharmaceutics11010029","article-title":"Transungual delivery of ciclopirox is increased 3-4-fold by mechanical fenestration of human nail plate in an in vitro model","volume":"11","author":"D\u00edaz","year":"2019","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2025.103992_bib0019","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2017.11.008","article-title":"Enhancement of tioconazole ungual delivery: combining nanocapsule formulation and nail poration approaches","volume":"535","author":"Flores","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.103992_bib0020","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2015.10.026","article-title":"Drug delivery into microneedle-porated nails from nanoparticle reservoirs","volume":"220","author":"Chiu","year":"2015","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.xphs.2025.103992_bib0021","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/PRS.0000000000005455","article-title":"Nanofat needling: a novel method for uniform delivery of adipose-derived stromal vascular fraction into the skin","volume":"143","author":"Verpaele","year":"2019","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.xphs.2025.103992_bib0022","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/pharmaceutics16010072","article-title":"New formulation\u2013microporation combination approaches to delivering ciclopirox across human nails","volume":"16","author":"Kishishita","year":"2024","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.xphs.2025.103992_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183335","article-title":"FT-IR investigation of terbinafine interaction with stratum corneum constituents","volume":"1862","author":"Pyatski","year":"2020","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.xphs.2025.103992_bib0024","unstructured":"DrugBank Online. Terbinafine hydrochloride. Available at: https:\/\/go.drugbank.com\/salts\/DBSALT000470. Last access: 18 july 2025."},{"issue":"Suppl 39","key":"10.1016\/j.xphs.2025.103992_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2133.1992.tb00001.x","article-title":"Terbinafine: mode of action and properties of the squalene epoxidase inhibition","volume":"126","author":"Ryder","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.xphs.2025.103992_bib0026","first-page":"49","article-title":"Update on terbinafine with a focus on dermatophytoses","volume":"2","author":"Newland","year":"2009","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"10.1016\/j.xphs.2025.103992_bib0027","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jps.23887","article-title":"Controlled-release injectable containing terbinafine\/PLGA microspheres for onychomycosis treatment","volume":"103","author":"Angamuthu","year":"2014","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2025.103992_bib0028","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1208\/s12249-016-0528-9","article-title":"Terbinafine hydrochloride trans-ungual delivery via nanovesicular systems: in vitro characterization and ex vivo evaluation","volume":"18","author":"Elsherif","year":"2017","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.xphs.2025.103992_bib0029","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1208\/s12249-017-0711-7","article-title":"Transungual gel of terbinafine hydrochloride for the management of onychomycosis: formulation, optimization, and evaluation","volume":"18","author":"Thatai","year":"2017","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.xphs.2025.103992_bib0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4155\/tde-2017-0069","article-title":"Terbinafine hydrochloride nail lacquer for the management of onychomycosis: formulation, characterization and in vitro evaluation","volume":"9","author":"Thatai","year":"2018","journal-title":"Ther Deliv"},{"issue":"5","key":"10.1016\/j.xphs.2025.103992_bib0031","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1208\/s12249-019-1429-5","article-title":"Fabrication of dissolvable microneedle patches using an innovative laser-cut mould design to shortlist potentially transungual delivery systems: in vitro evaluation","volume":"20","author":"Albarahmieh","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.xphs.2025.103992_bib0032","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1208\/s12249-011-9742-7","article-title":"Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using d-optimal design","volume":"13","author":"Barot","year":"2012","journal-title":"AAPS PharmSciTech"},{"issue":"4\u20135","key":"10.1016\/j.xphs.2025.103992_bib0033","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ejps.2012.12.014","article-title":"Novel topical formulations of terbinafine-HCl for treatment of onychomycosis","volume":"48","author":"Tanriverdi","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2025.103992_bib0034","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/08982104.2015.1067892","article-title":"Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation","volume":"26","author":"Tanriverdi","year":"2016","journal-title":"J Liposome Res"},{"key":"10.1016\/j.xphs.2025.103992_bib0035","series-title":"Off Gaz Fed Brazil","article-title":"Resolution RDC 166\/2017: validation of analytical methods","year":"2017"},{"issue":"4","key":"10.1016\/j.xphs.2025.103992_bib0036","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1208\/s12249-018-0995-2","article-title":"Microemulsion formulations for the transdermal delivery of lapachol","volume":"19","author":"Tabosa","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"10.1016\/j.xphs.2025.103992_bib0037","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1208\/s12249-016-0663-3","article-title":"Biopharmaceutical assessment and irritation potential of microemulsions and conventional systems containing oil from Syagrus cearensis for topical delivery of amphotericin B","volume":"18","author":"Sousa","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2025.103992_bib0038","article-title":"Antinociceptive activity of transdermal nanostructured surfactant-based systems containing duloxetine hydrochloride","volume":"101","author":"Seixas","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.xphs.2025.103992_bib0039","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mimet.2015.03.009","article-title":"Development of a novel in vitro onychomycosis model for the evaluation of topical antifungal activity","volume":"112","author":"Sleven","year":"2015","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.xphs.2025.103992_bib0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/0019-5154.123485","article-title":"Candida parapsilosis and Candida guillermondii: emerging pathogens in nail candidiasis","volume":"59","author":"Fich","year":"2014","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.xphs.2025.103992_bib0041","series-title":"Tratado De Micologia M\u00e9dica Lacaz","author":"Lacaz","year":"2002"},{"key":"10.1016\/j.xphs.2025.103992_bib0042","series-title":"British National Formulary [MedicinesComplete]","article-title":"Terbinafine","year":"2025"},{"key":"10.1016\/j.xphs.2025.103992_bib0043","series-title":"Pharmaceutical Skin Penetration Enhancement","first-page":"243","article-title":"Supersaturated solutions as topical drug delivery systems","author":"Davis","year":"1993"},{"key":"10.1016\/j.xphs.2025.103992_bib0044","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/antibiotics14050472","article-title":"MIC terbinafine resistance in Trichophyton rubrum and Trichophyton indotineae: a literature review","volume":"14","author":"Gupta","year":"2025","journal-title":"Antibiotics"},{"issue":"6","key":"10.1016\/j.xphs.2025.103992_bib0045","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0190-9622(94)70112-1","article-title":"Antifungal agents: an overview. Part II","volume":"30","author":"Gupta","year":"1994","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.xphs.2025.103992_bib0046","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0190-9622(96)90120-6","article-title":"Treatment of Candida nail infection with terbinafine","volume":"35","author":"Segal","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.xphs.2025.103992_bib0047","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.riam.2016.04.001","article-title":"The role of epidemiological cutoff values (ECVs\/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds","volume":"33","author":"Espinel-Ingroff","year":"2016","journal-title":"Rev Iberoam Micol"},{"issue":"5","key":"10.1016\/j.xphs.2025.103992_bib0048","first-page":"495","article-title":"Characterization of the antimicrobial susceptibility of fungi responsible for onychomycosis in Spain","volume":"49","author":"Zalacain","year":"2011","journal-title":"Med Mycol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:27:50Z","timestamp":1786649270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925004460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0022354925004460"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103992","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced terbinafine topical delivery to the nail by new formulation\u2013microporation approaches","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"103992"}}